Heart Test Laboratories Inc (HSCS) Stock Price, Quote & News

Company Profile

HeartSciences Inc., a medical technology company, focuses on applying AI-based technology to an ECG to expand and improve clinical usefulness. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction caused by heart disease and/or age-related cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction, as well as conventi...

Industry: Medical Devices

Sector: Healthcare

Phone: 682 237 7781

Website: heartsciences.com

Address:

550 Reserve Street, Suite 360, Southlake, United States

SporkGalaxy Apr. 24 at 11:13 PM

$HSCS on my radad

0 · Reply

DrTampa Apr. 21 at 10:00 AM

$HSCS Oh lawd, my pre market buying pissed off the algos 😂 140,000 shares already traded by 6am, algos pushed down from $2.78 to $1.87

0 · Reply

TheUnmaker Apr. 17 at 5:47 PM

$TNXP $HSCS $GRAL $BCDA

0 · Reply

TheUnmaker Apr. 16 at 7:05 AM

$TNXP $INBS $GRAL $HSCS sleeper bios that will

0 · Reply

Moneyybaggs Apr. 15 at 5:10 PM

$HSCS @DrTampa highlights a very interesting point. The maintenance requirement is so high because there is essentially no float. I think the FDS count is under 5 million shares. When Simpson drops a substantive PR HSCS’s SP will rocket upwards!!!

0 · Reply

DrTampa Apr. 15 at 12:55 AM

$HSCS a 400% maintenance requirement to short this stock is pretty crazy 🤪🤪 Could we see a rapid rise soon?!?

0 · Reply

Moneyybaggs Apr. 13 at 4:44 PM

$HSCS There is no bid and the only buyers are me and @DrTampa. FMTT!!!

1 · Reply

Moneyybaggs Apr. 12 at 4:44 PM

$HSCS SP needs to get above $3.50 before anyone buys the Reg A. And at a whopping $2.20 a share with a seller leaning on the bid HSCS has a ton of wood to chop!!! FMTT!!!

0 · Reply

DrTampa Apr. 10 at 9:19 PM

$HSCS Some highlights from the latest filing: We are currently in discussion with several third-party AI-ECG algorithm development companies to host their algorithms, including FDA cleared algorithms. In March 2026, we released a significant version upgrade for broader deployment across cardiology and healthcare IT environments. This release included mobile device access, enhanced reporting capabilities, and expanded interoperability designed to support integration across large health systems and enterprise environments. MyoVista Insights has also received Epic Toolbox designation for the ECG Management System category from Epic Systems Corporation. We believe this designation supports its positioning within enterprise healthcare IT ecosystems and may facilitate adoption within Epic-enabled health systems.

0 · Reply

DrTampa Apr. 10 at 9:14 PM

$HSCS the S-1 offering looks like its about to make a come back! https://s3.amazonaws.com/sec.irpass.cc/2729/0001213900-26-042552.htm

0 · Reply

HeartSciences Reminds Its Shareholders to Submit Their Vote at the Upcoming April 30, 2026, Annual Shareholders Meeting

Mar 25, 2026, 8:30 AM EDT - 4 weeks ago

HeartSciences' MyoVista Insights™ Receives Epic Toolbox Designation for ECG Management System Category

Mar 24, 2026, 11:18 AM EDT - 4 weeks ago

HeartSciences to Present at Investor Summit Group Virtual Conference and Host Virtual One on One Investor Meetings

Mar 16, 2026, 4:15 PM EDT - 5 weeks ago

HeartSciences Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update

Feb 5, 2026, 8:30 AM EST - 2 months ago

University of West England Adopts HeartSciences' MyoVista Insights™ Platform and MyoVista® wavECG™ Device to Establish ECG Education and Technology Reference Center

Jan 29, 2026, 8:30 AM EST - 3 months ago

Cibolo Health Designates HeartSciences' MyoVista Insights™ as Endorsed ECG Management Platform for Network of 123 Independent Hospitals

Dec 15, 2025, 4:15 PM EST - 4 months ago

HeartSciences Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update

Dec 15, 2025, 8:30 AM EST - 4 months ago

HeartSciences Announces FDA 510(k) Submission for MyoVista® wavECG™ Device

Dec 11, 2025, 8:30 AM EST - 4 months ago

HeartSciences Announces Major Upgrade to User Features of MyoVista Insights Platform with Commercial Launch Version 1.1

Sep 11, 2025, 4:15 PM EDT - 8 months ago

HeartSciences Provides Business Update and Reports First Quarter of Fiscal 2026 Financial Results

Aug 15, 2025, 9:00 AM EDT - 9 months ago

HeartSciences Announces Conference Participation and Investor Webinar

Jul 24, 2025, 4:15 PM EDT - 9 months ago

HeartSciences Provides Business Update and Reports Fiscal 2025 Financial Results

Jun 4, 2025, 9:00 AM EDT - 11 months ago

HeartSciences Receives FDA Breakthrough Device Designation for MyoVista Insights AI-ECG Algorithm for Detecting Aortic Stenosis

Jun 3, 2025, 9:00 AM EDT - 11 months ago

Foundational US Patent Granted for ECG Assessment of Heart Function, Further Expands HeartSciences' Patent Portfolio and IP Value

May 29, 2025, 9:00 AM EDT - 11 months ago

HeartSciences Signs First MyoVista Insights™ Platform Customer, Marking Major Commercial Milestone

May 20, 2025, 9:00 AM EDT - 1 year ago

HeartSciences' CEO Andrew Simpson to Present at Emerging Growth Conference 82 on Wednesday, May 21, 2025

May 8, 2025, 9:00 AM EDT - 1 year ago

HeartSciences to Host Investor Webinar and Q&A on Wednesday May 14, 2025 - Featuring CEO Andrew Simpson

May 7, 2025, 9:00 AM EDT - 1 year ago

HeartSciences Adds Prominent Key Advisors to its Scientific Advisory Board

May 1, 2025, 9:00 AM EDT - 1 year ago

HeartSciences Announces Launch of MyoVista Insights™ Platform and Related Early Adopter Program

Mar 13, 2025, 4:15 PM EDT - 1 year ago

HeartSciences Provides Business Update and Reports Third Quarter Fiscal 2025 Financial Results

Mar 10, 2025, 9:00 AM EDT - 1 year ago

HeartSciences Inc. Engages Integrous Communications to Enhance Investor Communications

Dec 16, 2024, 4:15 PM EST - 1 year ago

HeartSciences Provides Business Update and Reports Second Quarter Fiscal 2025 Financial Results

Nov 13, 2024, 9:00 AM EST - 1 year ago

HeartSciences' AI-ECG Algorithms Assigned CMS Medicare and Medicaid Reimbursement

Oct 14, 2024, 4:15 PM EDT - 1 year ago

HeartSciences to Participate in the 2024 Maxim Healthcare Virtual Summit

Sep 12, 2024, 4:15 PM EDT - 1 year ago

HeartSciences Provides Business Update and Reports First Quarter Fiscal 2025 Financial Results

Sep 12, 2024, 9:00 AM EDT - 1 year ago

HeartSciences Closes Non-Dilutive Financing to Increase its Cash Runaway Ahead of Upcoming FDA Submission

Jul 29, 2024, 4:05 PM EDT - 1 year ago

HeartSciences Provides Business Update and Reports Fiscal 2024 Financial Results

Jul 26, 2024, 9:00 AM EDT - 1 year ago

Innovation Value Institute Analysis Demonstrates HeartSciences' MyoVista® wavECG™ Potential to Improve Cardiovascular Pathway Efficiency

Jul 25, 2024, 8:30 AM EDT - 1 year ago

HeartSciences Selected to Demonstrate MyoVista® wavECG™ at the United Nations General Assembly Digital Health Symposium as a Technology to Radically Transform Healthcare

Jul 11, 2024, 9:00 AM EDT - 1 year ago

HeartSciences Announces Allowance of U.S Patent for AI-ECG Assessment of Left Ventricular and Right Ventricular Heart Dysfunction

Jun 4, 2024, 4:15 PM EDT - 2 years ago

HeartSciences Regains Compliance with Nasdaq Listing Requirements

May 20, 2024, 9:00 AM EDT - 2 years ago

HeartSciences Announces Further Internationalization of its AI-ECG Patent Portfolio

Apr 24, 2024, 9:00 AM EDT - 2 years ago

HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG

Apr 2, 2024, 4:15 PM EDT - 2 years ago

HeartSciences to Present at the LD Micro Invitational XIV Conference

Mar 26, 2024, 9:00 AM EDT - 2 years ago

HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista® Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients

Mar 14, 2024, 4:15 PM EDT - 2 years ago

HeartSciences Reports Third Quarter Fiscal 2024 Financial Results

Mar 12, 2024, 9:00 AM EDT - 2 years ago

HeartSciences' Announces Peer-Reviewed Publication Evaluating Use of MyoVista® Technology to Detect Asymptomatic Left Ventricular Dysfunction in Patients with Type 2 Diabetes

Mar 6, 2024, 9:00 AM EST - 2 years ago

HeartSciences Announces Canada Patent Grant Covering MyoVista® Wavelet Technology

Feb 26, 2024, 9:00 AM EST - 2 years ago

HeartSciences Adds Key Advisor to its Scientific Advisory Board

Feb 12, 2024, 9:00 AM EST - 2 years ago

HeartSciences Expands its Scientific Advisory Board

Feb 1, 2024, 9:00 AM EST - 2 years ago

HeartSciences Appoints New Scientific Advisory Board Member

Jan 18, 2024, 8:00 AM EST - 2 years ago

HeartSciences Announces Results and Adjournment of Annual Shareholder Meeting

Jan 3, 2024, 4:15 PM EST - 2 years ago

HeartSciences Reminds Stockholders to Vote at the Upcoming Annual Shareholder Meeting

Dec 14, 2023, 4:15 PM EST - 2 years ago

HeartSciences Reports Second Quarter Fiscal 2024 Financial Results

Dec 5, 2023, 8:00 AM EST - 2 years ago

HeartSciences Receives FDA Confirmation for 510(k) Clearance Pathway

Nov 13, 2023, 8:45 AM EST - 2 years ago

HeartSciences' MyoVista® wavECGTM Selected for Heart Screening of Irish Garda National Police Officers

Nov 3, 2023, 8:28 AM EDT - 2 years ago

Top 5 Health Care Stocks That Are Preparing To Pump In November - Better Therapeutics (NASDAQ:BTTX), Arcutis Biotherapeutics (NASDAQ:ARQT)

ARQT SINT

Sep 14, 2023, 4:15 PM EDT - 2 years ago

HeartSciences Reports First Quarter Fiscal 2024 Financial Results

Sep 12, 2023, 4:15 PM EDT - 2 years ago

HeartSciences to Present at the Gilmartin Group Emerging Growth Showcase

Sep 11, 2023, 4:15 PM EDT - 2 years ago

HeartSciences Named Electrocardiography Advancement Specialists of the Year 2023 - USA in the Global Health & Pharma Excellence Awards

SporkGalaxy Apr. 24 at 11:13 PM

$HSCS on my radad

0 · Reply

DrTampa Apr. 21 at 10:00 AM

$HSCS Oh lawd, my pre market buying pissed off the algos 😂 140,000 shares already traded by 6am, algos pushed down from $2.78 to $1.87

0 · Reply

TheUnmaker Apr. 17 at 5:47 PM

$TNXP $HSCS $GRAL $BCDA

0 · Reply

TheUnmaker Apr. 16 at 7:05 AM

$TNXP $INBS $GRAL $HSCS sleeper bios that will

0 · Reply

Moneyybaggs Apr. 15 at 5:10 PM

0 · Reply

DrTampa Apr. 15 at 12:55 AM

$HSCS a 400% maintenance requirement to short this stock is pretty crazy 🤪🤪 Could we see a rapid rise soon?!?

0 · Reply

Moneyybaggs Apr. 13 at 4:44 PM

$HSCS There is no bid and the only buyers are me and @DrTampa. FMTT!!!

1 · Reply

Moneyybaggs Apr. 12 at 4:44 PM

$HSCS SP needs to get above $3.50 before anyone buys the Reg A. And at a whopping $2.20 a share with a seller leaning on the bid HSCS has a ton of wood to chop!!! FMTT!!!

0 · Reply

DrTampa Apr. 10 at 9:19 PM

0 · Reply

DrTampa Apr. 10 at 9:14 PM

$HSCS the S-1 offering looks like its about to make a come back! https://s3.amazonaws.com/sec.irpass.cc/2729/0001213900-26-042552.htm

0 · Reply

Moneyybaggs Apr. 8 at 2:44 AM

$HSCS FDA APPROVAL SHOULD BE VERY SOON!!!

0 · Reply

DrTampa Apr. 7 at 7:36 PM

$HSCS wen FDA approval?

0 · Reply

Moneyybaggs Apr. 6 at 2:22 PM

$HSCS So tragic. My thoughts are with Mark Hilz’s family. Mark was an integral member of the team pushing HSCS’s cutting-edge technology forward. It’s unfortunate that he won’t see the fruits of his labor be validated but it’s going to happen and happen in the very near future. Rest in peace Mark Hilz.🙏🙏🙏

0 · Reply

DrTampa Apr. 6 at 2:45 AM

$HSCS rest in peace to Mark Hilz 😔😔 my condolences to his family and the entire HeartSciences team 🙏🙏

0 · Reply

focafoca99 Apr. 6 at 1:51 AM

$HSCS COO, corporate secretary and board member Mark Hilz passed away after an illness, so this is a leadership-loss update more than anything else.

1 · Reply

14745Barclay Apr. 5 at 3:48 AM

$HSCS The COO died of cancer. Is the company finally able to do something substantial now? He was largely missing from operation due to illness.

1 · Reply

SuperGreenToday Apr. 3 at 1:17 AM

$HSCS

0 · Reply

DisneyPalaceTrades Apr. 2 at 5:55 PM

$HSCS that s-1 open or no?

1 · Reply

Moneyybaggs Apr. 1 at 8:48 AM

$HSCS @DrTampa, somebody else, besides you and me, was FINALLY buying the stock yesterday!!! Let’s hope they’re back buying today. There is hardly any liquidity. SP was up 11% on just under 19K being traded. There’s hardly any shares in the float. Good luck building a sizable position without moving the SP $1-2. That PR last week regarding EPIC selection as a vendor in their web store is a GAME CHANGER!!! We are on the right train!!! UNCONTROLLABLY

1 · Reply

DrTampa Mar. 31 at 7:23 PM

$HSCS Nice inflow today with the share price up 11%

0 · Reply

DrTampa Mar. 30 at 4:43 PM

$HSCS that mid day spread tho 👀👀👀

0 · Reply

DrTampa Mar. 30 at 1:23 AM

$HSCS was so busy I missed this PR release last week, but it's now official news that Heart Sciences is listed on EPIC'S showroom! Now, we just need revenues!!! https://ir.heartsciences.com/release?i=163521

0 · Reply

Market Cap	2.27M
Revenue (ttm)	20,000.00
Net Income (ttm)	-6.61M
EPS (ttm)	N/A
PE Ratio	N/A
Forward PE	N/A
Profit Margin	N/A
Debt to Equity Ratio	N/A

Volume	11,938
Avg Vol	455,542
Day's Range	N/A - N/A
Shares Out	656,000.00
Stochastic %K	24%
Beta	3.16
Analysts	Strong Sell
Price Target	$13.50